The YAP1 mRNA level was reduced in dilated samples, suggesting that loss of YAP in the vascular wall associates with AAAs in humans (Figure 1A and Supplemental Table 1; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.170845DS1). This evidence concerns the gene YAP1 and achalasia-alacrima syndrome.